Sofosbuvir Active Not Recruiting Phase 2 Trials for Hepatitis C Virus Infection Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03022981Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection
NCT03820258Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) Infection